Scientific Data: In the SURPASS trials, tirzepatide showed higher rates of gastrointestinal side effects compared to semaglutide, but these were generally temporary and resolved as treatment continued
Summary: An FDA-approved oral option now expands choices beyond injectables or compounded semaglutide
As Spreckleys (2026) research found, GLP1 medications are effective for weight loss, a lack of appropriate nutrition oversight has lead to significant lean body mass loss and widespread nutritional deficiencies
The human body naturally makes a hormone called GLP-1, or Glucagon-Like Peptide-1
Retatrutide targets three receptors, which may translate into broader metabolic support for every dollar spent, depending on individual response
Whether a couple conceives is the question being asked